Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-10

Clinical Trial Update: A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SCH 697243 for grass pollen–related allergic rhinitis with allergic conjunctivitis, with or without asthma; results from the completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCH 697243 (SCH 697243)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinitis Allergic, Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2013-09-10